Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis.
A 1-year prospective cohort study of all episodes of Escherichia coli bacteraemia in two French university hospitals was conducted to assess simultaneously the influence of host and bacterial determinants on the initial severity and outcome of E. coli sepsis. Clinical data (community-acquired/nosocomial infection, immune status, underlying disease, primary source of infection, severity sepsis scoring and outcome), phylogenetic groups (A, B1, D and B2), nine virulence factors (VFs) (papC, papGII, papGIII, sfa/foc, hlyC, cnf1, iucC, fyuA and iroN) and the antibiotic susceptibility of isolates were investigated. All VFs except iucC were significantly more prevalent (p <0.05) among the B2 group isolates. The non-B2 isolates were more frequently resistant to antibiotics than were B2 isolates (p <0.05). There were significantly more B2 isolates from immunocompetent than from immunocompromised patients (p <0.05). No bacterial or host determinants influenced the initial severity of sepsis. Multivariate analysis revealed that the presence of papGIII, septic shock at baseline and a non-urinary tract origin of sepsis were associated independently with a fatal outcome (p 0.04, <0.0001 and 0.04, respectively). A factorial analysis of correspondence allowed two populations of isolates to be distinguished: those belonging to the B2 group were associated more frequently with susceptibility to antibiotics, community-acquired infection, a urinary tract origin and immunocompetent hosts; those belonging to the A, B1 or D groups were associated more frequently with resistance to antibiotics, a nosocomial origin, a non-urinary tract source and immunocompromised hosts. Although no influence of host or bacterial determinants on the initial severity of sepsis was detected, bacterial and host determinants both influenced the outcome of E. coli sepsis significantly.
Jauréguy
F
F
Hôpital Avicenne, AP-HP, UFR Santé, Médecine, Biologie Humaine, Université Paris 13, and INSERM Unité 570, Faculté de Médecine Necker-Enfants Malades, Université Paris 5, Paris, France.
Carbonnelle
E
E
Bonacorsi
S
S
Clec'h
C
C
Casassus
P
P
Bingen
E
E
Picard
B
B
Nassif
X
X
Lortholary
O
O
D016470:Bacteremia / Q000453:epidemiology / Q000382:microbiology; D004926:Escherichia coli / Q000472:pathogenicity*; D004927:Escherichia coli Infections / Q000209:etiology* / Q000276:immunology* / Q000382:microbiology; D006790:Host-Parasite Interactions; D006801:Humans; D034982:Integration Host Factors / Q000378:metabolism*; D011446:Prospective Studies; D018805:Sepsis / Q000209:etiology* / Q000382:microbiology; D037521:Virulence Factors / Q000235:genetics* / Q000378:metabolism
D034982:Integration Host Factors; D037521:Virulence Factors